- Home
- CIEN vs NBIX Comparison
CIEN vs NBIX Comparison
Compare CIEN & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIEN
- NBIX
- Stock Information
- Founded
- CIEN 1992
- NBIX 1992
- Country
- CIEN United States
- NBIX United States
- Employees
- CIEN N/A
- NBIX N/A
- Industry
- CIEN Telecommunications Equipment
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIEN Utilities
- NBIX Health Care
- Exchange
- CIEN Nasdaq
- NBIX Nasdaq
- Market Cap
- CIEN 27.4B
- NBIX 14.4B
- IPO Year
- CIEN 1997
- NBIX 1996
- Fundamental
- Price
- CIEN $191.10
- NBIX $144.77
- Analyst Decision
- CIEN Strong Buy
- NBIX Strong Buy
- Analyst Count
- CIEN 15
- NBIX 18
- Target Price
- CIEN $141.29
- NBIX $172.33
- AVG Volume (30 Days)
- CIEN 2.7M
- NBIX 1.1M
- Earning Date
- CIEN 12-11-2025
- NBIX 10-28-2025
- Dividend Yield
- CIEN N/A
- NBIX N/A
- EPS Growth
- CIEN 3.32
- NBIX 12.44
- EPS
- CIEN 0.98
- NBIX 4.19
- Revenue
- CIEN $4,541,635,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- CIEN $19.58
- NBIX $23.68
- Revenue Next Year
- CIEN $16.89
- NBIX $18.02
- P/E Ratio
- CIEN $195.70
- NBIX $34.56
- Revenue Growth
- CIEN 12.97
- NBIX 19.61
- 52 Week Low
- CIEN $49.21
- NBIX $84.23
- 52 Week High
- CIEN $214.17
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- CIEN 56.41
- NBIX 50.90
- Support Level
- CIEN $200.75
- NBIX $145.00
- Resistance Level
- CIEN $211.07
- NBIX $148.84
- Average True Range (ATR)
- CIEN 9.80
- NBIX 5.31
- MACD
- CIEN -1.36
- NBIX -0.33
- Stochastic Oscillator
- CIEN 41.39
- NBIX 47.17
About CIEN Ciena Corporation
Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.